MedTrace Logo

Risk Identification of the GlucoTab System in Routine Use

NCT02053077 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-05-12

Study results available
· View outcomes & findings →

Summary

Identification of risks of the GlucoTab system in routine use.

Conditions

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Thomas R. Pieber, Univ.Prof.Dr · Medical University of Graz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-06-30
Completion
2016-06-26

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02053077 on ClinicalTrials.gov